Middle East & Africa Drug Screening Market Outlook, 2028

The Middle East and Africa are crucial markets for drug screening and are likely to develop at a significant rate during the forecast period due to rising drug consumption and strong legislation demanding drug testing, which are the primary drivers of the drug screening market in the Middle East and Africa. The increased use of drugs among adults in developing countries such as South Africa has harmed employment and altered the country's economic position, influencing market growth significantly. Furthermore, the increase in tight government rules and regulations for limiting drug use, growing awareness about drug screening policies, and excessive drug consumption with its repercussions are expected to drive market expansion. Furthermore, increased activities and funding from government and non-government organisations in research and development for developing advanced and efficient screening devices will improve the demand in the market.

Regulatory frameworks for drug screening vary across countries in the Middle East & Africa region, with some countries implementing strict measures while others are in the process of establishing or modifying rules. The progressive tightening of workplace safety laws, notably in industries such as oil and gas, construction, and transportation, has increased demand for robust and dependable drug screening solutions. Companies in these industries frequently require pre-employment and random drug tests to provide a safe working environment, fueling the expansion of the drug screening market. Technological improvements have a significant impact on the Middle East & Africa drug screening industry.

The emergence of novel screening methods and equipment, such as point-of-care testing, improved analytical machines, and portable testing kits, has transformed the landscape. These technologies offer increased accuracy, sensitivity, and the ability to detect a wider range of substances, meeting the diverse needs of industries and enabling more efficient and timely screening processes.

According to the research report,"Middle East & Africa Drug Screening Market Outlook, 2028,", the Middle East & Africa Drug Screening market is anticipated to add more than USD 169 Million market size from 2023 to 2028. Drug screening is used in a variety of ways in the Middle East & Africa region's healthcare sector. It includes everything from clinical diagnostics to drug misuse monitoring and medication adherence programmes. Drug screening is increasingly being used in healthcare facilities to aid in patient treatment regimens and maintain medication adherence. Furthermore, the region's sports business emphasises fair play and integrity, requiring severe drug testing standards in athletic competitions to prevent doping scandals and maintain sports event credibility. Several developing trends in the Middle East & Africa drug screening market are redefining the business.

One notable development is the growing use of alternative drug testing sample types such as hair, saliva, and sweat. These alternate specimens provide benefits such as longer detection windows and non-invasiveness, appealing to both testing facilities and individuals undergoing screening. Different industries in the Middle East & Africa region have different drug screening needs. As of the high-risk nature of its activities, the oil and gas industry, for example, prioritises safety, resulting in severe drug testing methods. Similarly, healthcare facilities place a premium on drug adherence and monitoring, necessitating the use of specific testing methods. Some countries in the region are strengthening their efforts to combat substance misuse through public health initiatives. Drug screening is critical in these projects because it identifies people who require intervention and treatment.

Based on report market is divided into three major countries, United Arab Emirates, Saudi Arabia and South Africa. Saudi Arabia is expected to play crucial role in Middle East & Africa drug screening market.

The Saudi drug testing sector is a vital component of the country's healthcare system, driven by a number of factors peculiar to the country's social, economic, and regulatory dynamics. Saudi Arabia maintains strong drug-abuse regulations in accordance with Islamic law and cultural norms. The country imposes high penalties for drug-related offences, which fuels demand for reliable drug testing technologies in a range of businesses. Drug testing in compliance with worldwide workplace safety standards is essential for ensuring a drug-free environment in Saudi Arabia's industries. To increase safety standards and regulatory compliance, industries such as oil and gas, construction, and transportation prioritise drug screening. A new research hub in Saudi Arabia is accelerating drug discovery and development. The centre works with organisations such as the Academic Drug Discovery Consortium in the United States.

Similarly, the King Abdullah International Medical Research Centre (KAIMRC) in Saudi Arabia is attempting to transform clinical research and pharmaceutical discovery. The Saudi Food and Drug Authority (SFDA) is responsible for ensuring the safety of food, pharmaceuticals, biological and chemical substances, and electronic devices in Saudi Arabia. Saudi Arabia's approach to drug screening is heavily impacted by cultural and religious norms. The country adheres to Islamic values, and its rigorous cultural standards influence how individuals perceive and deal with drug-related issues.

Based on product and service segment market is bifurcated into consumables, analytical instruments, rapid testing devices, and drug screening service. Rapid testing services are expected to grow at rapid pace in Middle East & Africa drug screening market. Based on sample type market is segmented into urine samples, breath samples, hair samples, oral fluid samples, and other samples.

In comparison to typical laboratory-based approaches, rapid testing services provide results quickly, frequently within minutes. In industries such as transportation, construction, and oil and gas, where safety is vital, the ability to receive quick results is critical for making timely decisions about employee fitness for duty. Rapid testing services frequently allow for on-site testing, avoiding the need to transport samples to off-site laboratories. This functionality is especially useful in remote regions or businesses where fast testing is required, allowing for swift responses depending on test results.

Technological advancements have resulted in the creation of portable and user-friendly fast-testing instruments. These devices are simpler to use and require little training, making them more accessible to a wider range of industries and testing facilities. Oral fluid samples are frequently gaining adoption in Middle East & Africa for drug screening.

Oral fluid sampling is non-invasive and includes collecting a saliva sample, which is less difficult, painless, and scary than other methods such as blood or urine collection. This simplicity improves user acceptance and compliance, especially in cases requiring frequent or random testing. Oral fluid samples can be taken right away, decreasing the possibility of sample tampering or substitution. This promptness contributes to the testing process's integrity, especially when there are worries regarding sample manipulation. Oral fluid testing detects active drug usage rather than residual drug traces, offering a real-time view of a person's current substance use. This rapid detection aligns with the requirement to detect impairment or recent drug use, particularly in safety-critical workplaces.

Based on end user segment market is segmented into laboratories, workplaces, hospitals, and others. Workplaces end user segment is expected to grow at significant pace in Middle East & Africa drug screening market.

Providing a safe working environment is a primary issue for employers across the Middle East & Africa region. Workplace drug testing is critical for maintaining safety standards, especially in areas where safety risks are inherent, such as construction, transportation, oil and gas, and manufacturing. Employers use drug testing as a risk management strategy to reduce potential liability stemming from workplace accidents, injuries, or errors caused by impaired staff. Companies hope to identify and manage risks associated with substance usage in the workplace by conducting regular or random drug tests.

Transportation and oil and gas industries, for example, have unique safety-sensitive jobs where impairment due to substance use poses considerable dangers. Employers in these industries frequently have strict drug testing protocols in place to ensure employee safety standards and prevent accidents or hazards.

Employers in the Middle East & Africa region are becoming more conscious of the need for workplace drug screening to foster a safe and productive work environment. This changing attitude towards occupational safety adds to the rising use of drug testing programmes. Drug screening Technological advancements, such as quick testing equipment and more accurate screening procedures, make drug testing more accessible, efficient, and cost-effective in the workplace, increasing its use.

Companies Covered in this report:

Abbott Laboratories, Drägerwerk AG & Co. KGaA, Siemens Healthineers, Shimadzu Corporation, F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific Inc

Considered in this report:

• Geography: Middle East & Africa
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:

• Middle East & Africa Drug Screening market Outlook with its value and forecast along with its segments
• Country-wise Drug Screening market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Country covered in the report:

• United Arab Emirates
• Saudi Arabia
• South Africa

By Product and Service:

• Consumables
• Analytical Instruments
• Rapid Testing Devices
• Drug Screening Service

By Sample Type:

• Urine Samples
• Breath Samples
• Hair Samples
• Oral Fluid Samples
• Other Samples

By End User:

• Laboratories
• Workplaces
• Hospitals
• Others

The approach of the report:

This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.

Intended audience:

This report can be useful to industry consultants, manufacturers, suppliers, associations, and organisations related to the Drug Screening industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.


This product will be delivered within 2 business days.